Reading Time: 3 minutesA recent press release by the pharmaceutical company Biogen reported preliminary results from an ongoing clinical trial investigating a form of precision therapy in people … Continue reading Tofersen: antisense oligonucleotide drug shows promising results in Phase 1/2 trial